Commission Directive 2011/25/EU of 3 March 2011 amending Council Directive 91/414/EEC to include bupirimate as active substance and amending Commission Decision 2008/934/EC Text with EEA relevance
(a) in the case of a product containing bupirimate as the only active substance, where necessary, amend or withdraw the authorisation by 31 May 2015 at the latest; or(b) in the case of a product containing bupirimate as one of several active substances, where necessary, amend or withdraw the authorisation by 31 May 2015 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
No | Common name, identification numbers | IUPAC name | Purity | Entry into force | Expiration of inclusion | Specific provisions |
---|---|---|---|---|---|---|
"337 | 5-butyl-2-ethylamino-6-methylpyrimidine-4-yl dimethylsulfamate |
|
----------------------